NOAC Dosing for Obese Patients vs. Non-Obese Patients

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.

This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.